Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
An update on methotrexate pharmacogenetics in rheumatoid arthritis
Prabha Ranganathan
Division of Rheumatology
Institute of Clinical and Translational Sciences (ICTS)
Division of Veterans Affairs
Rheumatic Diseases Research Resource-Based Center
Research output
:
Contribution to journal
›
Review article
›
peer-review
54
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'An update on methotrexate pharmacogenetics in rheumatoid arthritis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Rheumatoid Arthritis
100%
Pharmacogenetics
100%
Methotrexate
100%
Disease-modifying Antirheumatic Drugs (DMARDs)
60%
Patient Response
40%
Joint Damage
40%
High Morbidity
20%
High Mortality
20%
Long-term Safety
20%
Clinical Symptoms
20%
Clinical Signs
20%
Long-term Efficacy
20%
Systemic Inflammatory Response Syndrome
20%
Rheumatoid Arthritis Treatment
20%
Disease Symptoms
20%
Radiographic Progression
20%
Methotrexate Treatment
20%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
100%
Pharmacogenetics
100%
Methotrexate
100%
Inflammatory Arthritis
100%
Disease Modifying Antirheumatic Drug
50%
Diseases
50%
Physical Disease by Body Function
16%